ArticleSultan Qaboos University medical journal2022

Evaluation of Ruxolitinib versus Best Available Therapy in Treating Primary Myelofibrosis.

Kawa M Hasan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.